The outlay of Retatrutide is currently a major concern for patients . Initial figures place the annual cost at upwards of a large sum of dollars, conceivably making it inaccessible for many. Several factors influence the overall payment, including coverage status , dosage required, and the provider chosen. Further investigation into options for low